Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

SMARCA4 regulates the NK-mediated killing of senescent cells

V. Reen, M. D'Ambrosio, PP. Søgaard, K. Tyson, BJ. Leeke, I. Clément, ICA. Dye, J. Pombo, A. Kuba, Y. Lan, J. Burr, IC. Bomann, M. Kalyva, J. Birch, S. Khadayate, G. Young, D. Provencher, AM. Mes-Masson, S. Vernia, N. McGranahan, HJM. Brady, F....

. 2025 ; 11 (3) : eadn2811. [pub] 20250115

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25010240

Grantová podpora
Wellcome Trust - United Kingdom
MC_UP_1102/18 Medical Research Council - United Kingdom

Induction of senescence by chemotherapeutic agents arrests cancer cells and activates immune surveillance responses to contribute to therapy outcomes. In this investigation, we searched for ways to enhance the NK-mediated elimination of senescent cells. We used a staggered screen approach, first identifying siRNAs potentiating the secretion of immunomodulatory cytokines to later test for their ability to enhance NK-mediated killing of senescent cells. We identified that genetic or pharmacological inhibition of SMARCA4 enhanced senescent cell elimination by NK cells. SMARCA4 expression is elevated during senescence and its inhibition derepresses repetitive elements, inducing the SASP via activation of cGAS/STING and MAVS/MDA5 pathways. Moreover, a PROTAC targeting SMARCA4 synergized with cisplatin to increase the infiltration of CD8 T cells and mature, activated NK cells in an immunocompetent model of ovarian cancer. Our results indicate that SMARCA4 inhibitors enhance NK-mediated surveillance of senescent cells and may represent senotherapeutic interventions for ovarian cancer.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25010240
003      
CZ-PrNML
005      
20250429135422.0
007      
ta
008      
250415s2025 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1126/sciadv.adn2811 $2 doi
035    __
$a (PubMed)39813356
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Reen, Virinder $u MRC Laboratory of Medical Sciences (LMS), Du Cane Road, London W12 0NN, UK $u Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, Du Cane Road, London W12 0NN, UK $1 https://orcid.org/0009000889039636
245    10
$a SMARCA4 regulates the NK-mediated killing of senescent cells / $c V. Reen, M. D'Ambrosio, PP. Søgaard, K. Tyson, BJ. Leeke, I. Clément, ICA. Dye, J. Pombo, A. Kuba, Y. Lan, J. Burr, IC. Bomann, M. Kalyva, J. Birch, S. Khadayate, G. Young, D. Provencher, AM. Mes-Masson, S. Vernia, N. McGranahan, HJM. Brady, F. Rodier, R. Nativio, M. Percharde, IA. McNeish, J. Gil
520    9_
$a Induction of senescence by chemotherapeutic agents arrests cancer cells and activates immune surveillance responses to contribute to therapy outcomes. In this investigation, we searched for ways to enhance the NK-mediated elimination of senescent cells. We used a staggered screen approach, first identifying siRNAs potentiating the secretion of immunomodulatory cytokines to later test for their ability to enhance NK-mediated killing of senescent cells. We identified that genetic or pharmacological inhibition of SMARCA4 enhanced senescent cell elimination by NK cells. SMARCA4 expression is elevated during senescence and its inhibition derepresses repetitive elements, inducing the SASP via activation of cGAS/STING and MAVS/MDA5 pathways. Moreover, a PROTAC targeting SMARCA4 synergized with cisplatin to increase the infiltration of CD8 T cells and mature, activated NK cells in an immunocompetent model of ovarian cancer. Our results indicate that SMARCA4 inhibitors enhance NK-mediated surveillance of senescent cells and may represent senotherapeutic interventions for ovarian cancer.
650    12
$a stárnutí buněk $x účinky léků $7 D016922
650    12
$a buňky NK $x imunologie $x metabolismus $x účinky léků $7 D007694
650    _2
$a lidé $7 D006801
650    12
$a transkripční faktory $x metabolismus $x genetika $7 D014157
650    12
$a DNA-helikasy $x metabolismus $x genetika $7 D004265
650    12
$a jaderné proteiny $x metabolismus $x genetika $7 D009687
650    _2
$a zvířata $7 D000818
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a nádory vaječníků $x farmakoterapie $x metabolismus $x patologie $x genetika $x imunologie $7 D010051
650    _2
$a myši $7 D051379
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a signální transdukce $x účinky léků $7 D015398
655    _2
$a časopisecké články $7 D016428
700    1_
$a D'Ambrosio, Mariantonietta $u MRC Laboratory of Medical Sciences (LMS), Du Cane Road, London W12 0NN, UK $u Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, Du Cane Road, London W12 0NN, UK
700    1_
$a Søgaard, Pia Pernille $u MRC Laboratory of Medical Sciences (LMS), Du Cane Road, London W12 0NN, UK $u Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, Du Cane Road, London W12 0NN, UK $1 https://orcid.org/0000000191751819
700    1_
$a Tyson, Katie $u Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK $1 https://orcid.org/000900070339514X
700    1_
$a Leeke, Bryony J $u MRC Laboratory of Medical Sciences (LMS), Du Cane Road, London W12 0NN, UK $u Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, Du Cane Road, London W12 0NN, UK $1 https://orcid.org/0000000255728942
700    1_
$a Clément, Isabelle $u Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM) et Institut du Cancer de Montréal, Montreal, QC, Canada $u Département de Radiologie, Radio-oncologie et Médicine Nucléaire, Université de Montréal, Montreal, QC, Canada
700    1_
$a Dye, Isabel C A $u Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK $1 https://orcid.org/0009000108775025
700    1_
$a Pombo, Joaquim $u MRC Laboratory of Medical Sciences (LMS), Du Cane Road, London W12 0NN, UK $u Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, Du Cane Road, London W12 0NN, UK
700    1_
$a Kuba, Adam $u Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM) et Institut du Cancer de Montréal, Montreal, QC, Canada $u Département de Radiologie, Radio-oncologie et Médicine Nucléaire, Université de Montréal, Montreal, QC, Canada $u Department of Hemato-Oncology, University Hospital and Faculty of Medicine and Dentistry Palacky University, Olomouc, Czech Republic $1 https://orcid.org/0000000288115966
700    1_
$a Lan, Yemin $u Department of Brain Sciences, Imperial College London, London, UK $u UK Dementia Research Institute, Imperial College London, London, UK $1 https://orcid.org/0000000334553618
700    1_
$a Burr, Joanna $u Department of Life Sciences, Imperial College, London SW7 2AZ, UK $1 https://orcid.org/000900061981978X
700    1_
$a Bomann, Ida C $u Department of Brain Sciences, Imperial College London, London, UK $u UK Dementia Research Institute, Imperial College London, London, UK $1 https://orcid.org/0009000436288023
700    1_
$a Kalyva, Maria $u Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK $1 https://orcid.org/0000000248916152
700    1_
$a Birch, Jodie $u MRC Laboratory of Medical Sciences (LMS), Du Cane Road, London W12 0NN, UK $u Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, Du Cane Road, London W12 0NN, UK $1 https://orcid.org/0000000317271125
700    1_
$a Khadayate, Sanjay $u MRC Laboratory of Medical Sciences (LMS), Du Cane Road, London W12 0NN, UK $u Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, Du Cane Road, London W12 0NN, UK $1 https://orcid.org/0000000342786403
700    1_
$a Young, George $u MRC Laboratory of Medical Sciences (LMS), Du Cane Road, London W12 0NN, UK $u Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, Du Cane Road, London W12 0NN, UK $1 https://orcid.org/000000021203588X
700    1_
$a Provencher, Diane $u Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM) et Institut du Cancer de Montréal, Montreal, QC, Canada $u Département d'Obstétrique-Gynécologie, Université de Montréal, Montreal, QC, Canada $1 https://orcid.org/0000000319023256
700    1_
$a Mes-Masson, Anne-Marie $u Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM) et Institut du Cancer de Montréal, Montreal, QC, Canada $u Département de Médecine, Université de Montréal, Montreal, QC, Canada $1 https://orcid.org/000000026498266X
700    1_
$a Vernia, Santiago $u MRC Laboratory of Medical Sciences (LMS), Du Cane Road, London W12 0NN, UK $u Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, Du Cane Road, London W12 0NN, UK $u Instituto de Biomedicina de Valencia IBV-CSIC, Valencia 46012, Spain $1 https://orcid.org/0000000167285555
700    1_
$a McGranahan, Nicholas $u Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK $u Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK
700    1_
$a Brady, Hugh J M $u Department of Hemato-Oncology, University Hospital and Faculty of Medicine and Dentistry Palacky University, Olomouc, Czech Republic $1 https://orcid.org/000000023152067X
700    1_
$a Rodier, Francis $u Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM) et Institut du Cancer de Montréal, Montreal, QC, Canada $u Département de Radiologie, Radio-oncologie et Médicine Nucléaire, Université de Montréal, Montreal, QC, Canada $1 https://orcid.org/000000032523309X
700    1_
$a Nativio, Raffaella $u Department of Brain Sciences, Imperial College London, London, UK $u UK Dementia Research Institute, Imperial College London, London, UK $1 https://orcid.org/0000000212497072
700    1_
$a Percharde, Michelle $u MRC Laboratory of Medical Sciences (LMS), Du Cane Road, London W12 0NN, UK $u Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, Du Cane Road, London W12 0NN, UK $1 https://orcid.org/0000000179284955
700    1_
$a McNeish, Iain A $u Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK $1 https://orcid.org/0000000293877586
700    1_
$a Gil, Jesús $u MRC Laboratory of Medical Sciences (LMS), Du Cane Road, London W12 0NN, UK $u Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, Du Cane Road, London W12 0NN, UK $1 https://orcid.org/0000000243036260
773    0_
$w MED00188818 $t Science advances $x 2375-2548 $g Roč. 11, č. 3 (2025), s. eadn2811
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39813356 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429135417 $b ABA008
999    __
$a ok $b bmc $g 2311544 $s 1247321
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 11 $c 3 $d eadn2811 $e 20250115 $i 2375-2548 $m Science advances $n Sci Adv $x MED00188818
GRA    __
$p Wellcome Trust $2 United Kingdom
GRA    __
$a MC_UP_1102/18 $p Medical Research Council $2 United Kingdom
LZP    __
$a Pubmed-20250415

Najít záznam

Citační ukazatele

Možnosti archivace